A chemist, she lent her expertise in drug research to ACT UP, an organization known for its street protests, and helped accelerate the approval of H.I.V. and AIDS treatments.
The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, saying it unfairly lumped failed drugs with two recently approved treatments.